Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Response to Salvage Therapies and Outcome of Patients with Multiple Myeloma Relapsing After Pomalidomide Therapy

Shirshendu Sinha, MBBS, Shaji Kumar, MD, Suzanne Hayman, MD, Francis Buadi, MD, Kristen Detweiler Short, RN, CNP, Joseph Mikhael, MD, Angela Dispenzieri, MD, Morie Gertz, MD, David Dingli, M.D., Ph.D., S. Vincent Rajkumar, MD, Martha Lacy, MD

Blood (2010) 116 (21): 1965.

https://doi.org/10.1182/blood.V116.21.1965.1965

Published: 2010

Journal Articles

Peripheral Blood Stem Cell Collection In Patients Undergoing Induction Therapy with Lenalidomide Based Regimens: Failure Rates and Salvage Approaches

Shirshendu Sinha, MBBS, Morie Gertz, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Suzanne Hayman, MD, Francis Buadi, MD, David Dingli, MD, Ph.D., Ivana Micallef, MD, William Hogan, MBBCh, Dennis Gastineau, MD, S. Vincent Rajkumar, MD, Shaji Kumar, MD

Blood (2010) 116 (21): 2253.

https://doi.org/10.1182/blood.V116.21.2253.2253

Published: 2010

Journal Articles

Evidence for Cytogenetic and Fluorescence in Situ Hybridization (FISH) Risk Stratification of Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies.

Prashant Kapoor, MD, Rafael Fonseca, MD, S. Vincent Rajkumar, MD, Shirshendu Sinha, MBBS, Morie A. Gertz, MD, A. Keith Stewart, MD, P. Leif Bergsagel, MD, Martha Q. Lacy, MD, David Dingli, M.D., PhD., Rhett P. Ketterling, MD, Robert Kyle, M.D., Philip R. Greipp, MD, Angela Dispenzieri, MD, Shaji Kumar, MD

Blood (2009) 114 (22): 1802.

https://doi.org/10.1182/blood.V114.22.1802.1802

Published: 2009

Journal Articles

Predicting Poor Peripheral Blood Stem Cell Mobilization Using Initial Peripheral CD34 Counts in Patients with Lymphoma.

Shirshendu Sinha, MBBS, Shaji Kumar, MD, Dennis A. Gastineau, MD, William Hogan, MD, Francis Buadi, MD, David Dingli, PhD., M.D., Angela Dispenzieri, MD, Morie A Gertz, MD, Carl Greiner, Suzzane Hayman, MD, David Inwards, MD, Patrick B Johnston, MD, PhD, Martha Q. Lacy, MD, Mark R. Litzow, MD, Luis F. Porrata, MD, Jeffrey Winters, MD, Ivana N Micallef, MD

Blood (2009) 114 (22): 4228.

https://doi.org/10.1182/blood.V114.22.4228.4228

Published: 2009

Journal Articles

Predicting Poor Peripheral Blood Stem Cell Mobilization in Multiple Myeloma (MM) Using Initial Peripheral CD34 Counts: Developing Target-Based Cut-Points for Early Intervention.

Shirshendu Sinha, MBBS, Dennis A. Gastineau, MD, William J. Hogan, MBBCh, Ivana N Micallef, MD, Francis K. Buadi, MD, David Dingli, M.D., PhD., Angela Dispenzieri, MD, Morie A. Gertz, MD, Carl Greiner, Suzzane Hayman, MD, David J. Inwards, MD, Patrick B. Johnston, MD.Ph.D, Martha Q. Lacy, MD, Mark R. Litzow, MD, Luis F. Porrata, MD, Jeffrey Winters, MD, Shaji Kumar, MD

Blood (2009) 114 (22): 3231.

https://doi.org/10.1182/blood.V114.22.3231.3231

Published: 2009

NARROW

Response to Salvage Therapies and Outcome of Patients with Multiple Myeloma Relapsing After Pomalidomide Therapy

Peripheral Blood Stem Cell Collection In Patients Undergoing Induction Therapy with Lenalidomide Based Regimens: Failure Rates and Salvage Approaches

Evidence for Cytogenetic and Fluorescence in Situ Hybridization (FISH) Risk Stratification of Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies.

Predicting Poor Peripheral Blood Stem Cell Mobilization Using Initial Peripheral CD34 Counts in Patients with Lymphoma.

Predicting Poor Peripheral Blood Stem Cell Mobilization in Multiple Myeloma (MM) Using Initial Peripheral CD34 Counts: Developing Target-Based Cut-Points for Early Intervention.

Email alerts

ASH Publications

American Society of Hematology

Response to Salvage Therapies and Outcome of Patients with Multiple Myeloma Relapsing After Pomalidomide Therapy

Peripheral Blood Stem Cell Collection In Patients Undergoing Induction Therapy with Lenalidomide Based Regimens: Failure Rates and Salvage Approaches

Evidence for Cytogenetic and Fluorescence in Situ Hybridization (FISH) Risk Stratification of Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies.

Predicting Poor Peripheral Blood Stem Cell Mobilization Using Initial Peripheral CD34 Counts in Patients with Lymphoma.

Predicting Poor Peripheral Blood Stem Cell Mobilization in Multiple Myeloma (MM) Using Initial Peripheral CD34 Counts: Developing Target-Based Cut-Points for Early Intervention.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only